Hitachi's Heavy Ion Beam Therapy System Starts Treatment at Osaka Heavy Ion Therapy Center

Oct 16, 2018 14:43 JST

Source: Hitachi, Ltd.

TOKYO, Oct 16, 2018 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) announced today that its heavy ion beam therapy system(1) has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi's first heavy ion therapy system.

Osaka Heavy Ion Therapy Center

Treatment Room

The system, consisting of two treatment rooms with vertical and horizontal ports and one treatment room with horizontal and oblique ports, is equipped with scanning technology for treating certain forms of cancer and will have the feature of real-time image gating for tracking movement of organs during respiration(2). Hitachi has also delivered particle therapy treatment planning will utilize imaging data and calculate the appropriate dose to prepare the most suitable, patient-specific treatment plans(3).

Osaka Heavy Ion Therapy Center, located in the heart of Osaka city with easy access and a view of Osaka Castle, has adopted a universal design concept in accordance with basic principles of safety and comfort and aims to deliver more pleasant cancer treatments to patients. The patient and medical staff friendly system and spatial design have been highly acclaimed, resulting in the winning of 2018 Good Design Award sponsored by the Japan Institute of Design Promotion, a public interest incorporated foundation.

Hitachi has been proactively promoting the particle therapy business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems that have treated more than 16,000 patients. Hitachi integrated Mitsubishi Electric Corporation's particle therapy system business in June 2018 into its own business unit. Hitachi will utilize the technology with their experience in particle therapy system and contribute in providing cutting edge radiation therapy. Under the new structure, Hitachi will provide products and services with higher performance and added value, including a Single Room Solution and a Hybrid System combined with the capabilities of proton and carbon therapy.

As Hitachi expands its healthcare business, it will continue to accelerate the globalization of its particle therapy system business and contribute to cancer treatment around the world.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment. The use of particle therapy is expected to increase.

(1) The system obtained manufacturing and marketing approval in accordance with Pharmaceutical and Medical Device Act on September 25, 2018.
(2) Real-time image gating is the technology collaboratively developed between Hokkaido University and Hitachi, supported by Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) of Japan Society for the Promotion of Science.
(3) The system obtained manufacturing and marketing approval in accordance with Pharmaceutical and Medical Device Act on October 10, 2018.

Contact:

Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111

Source: Hitachi, Ltd.
Sectors: BioTech

Related Press Release

Hitachi Energy and SP Energy Networks to boost renewable energy flow

April 05 2024 16:15 JST

Hitachi Selected as "Excellent TCFD Disclosure" by GPIF's External Asset Managers for the Third Consecutive Year

April 05 2024 16:00 JST

JFE Steel and Hitachi Jointly Started Providing Solutions for the Steel Industry

March 26 2024 18:04 JST

Hitachi Selected as CDP Supplier Engagement Leader for the Third Consecutive Year

March 22 2024 15:04 JST

Hitachi Collaborates with NVIDIA to Accelerate Digital Transformation with Generative AI

March 19 2024 18:11 JST

Hitachi Vantara Announces Collaboration with NVIDIA to Create New Portfolio of Industrial AI Solutions

March 19 2024 11:35 JST

Hitachi High-Tech Launches High-sensitivity and High-throughput Wafer Surface Inspection System LS9300AD for Wafer Manufacturers

March 15 2024 10:21 JST

Hitachi Forges a Three Year Strategic Alliance with AWS to Advance Hybrid Cloud Solutions

March 11 2024 15:44 JST

Hitachi Energy and TransnetBW make German grid fit for future

February 15 2024 10:22 JST

Contributing to Efficient Development of Metal Thin Film Materials by Using Chemicals Informatics and Materials Informatics

February 09 2024 12:41 JST

More Press release >>

Latest Press Release

Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST

Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST

New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST

TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST

Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST

MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST

Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST

DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST

Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST

Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST

DENSO, Companies Initiate Demonstration to Expand Automotive Recycling Process
Apr 09, 2024 19:07 JST

Mitsubishi Power Receives Order from HK Electric for Natural-gas-fired GTCC Power Generation Equipment
Apr 09, 2024 15:04 JST

MHI Thermal Systems Adds New KXZ3 Series of Building-use Multi-Split Air- Conditioners Adopting R32 Refrigerant
Apr 09, 2024 13:40 JST

Fujitsu AI transforms manufacturing lines with new quality control system for REHAU
Apr 09, 2024 10:39 JST

NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
Apr 08, 2024 13:45 JST

Daihatsu and Toyota to Reform Structures towards the Revitalization of Daihatsu
Apr 08, 2024 13:37 JST

Hitachi Energy and SP Energy Networks to boost renewable energy flow
Apr 05, 2024 17:15 JST

Hitachi Selected as "Excellent TCFD Disclosure" by GPIF's External Asset Managers for the Third Consecutive Year
Apr 05, 2024 17:00 JST

Mitsubishi Corporation: Sale of BMA Coal Assets in Queensland Completed
Apr 03, 2024 19:05 JST

More Latest Release >>